cyclohexanol has been researched along with tamoxifen in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiki, H; Iida, N; Kim, SJ; Komori, A; Okabe, S; Sueoka, E; Suganuma, M | 1 |
| Gao, S; Singh, J | 1 |
| Bydder, SA; Spry, NA | 1 |
| Goetz, MP; Loprinzi, CL | 1 |
| Calder, RJ; Heard, CM; Ho, S; Thomas, CP | 1 |
| Araba, A; Blanchard, R; Desta, Z; Flockhart, DA; Hayden, J; Hayes, DF; Ho, H; Jin, Y; Lee, KH; Lemler, S; Li, L; Nguyen, A; Rae, JM; Skaar, T; Stearns, V; Storniolo, AM; Ullmer, L; Ward, B; Weinshilboum, RM | 1 |
| Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V | 1 |
| Barton, DL | 1 |
| Desmarais, JE; Looper, KJ | 1 |
| Ford, BM; Franks, LN; Prather, PL; Radominska-Pandya, A | 1 |
3 review(s) available for cyclohexanol and tamoxifen
| Article | Year |
|---|---|
A hot flash on tamoxifen metabolism.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride | 2003 |
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride | 2009 |
7 other study(ies) available for cyclohexanol and tamoxifen
| Article | Year |
|---|---|
A new process of cancer prevention mediated through inhibition of tumor necrosis factor alpha expression.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Base Sequence; Catechin; Cyclohexanols; Diterpenes; Humans; Mice; Molecular Sequence Data; Proto-Oncogenes; Tamoxifen; Tumor Necrosis Factor-alpha | 1996 |
In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents, Hormonal; Cyclohexane Monoterpenes; Cyclohexanols; Epidermis; Eucalyptol; Female; In Vitro Techniques; Menthol; Monoterpenes; Skin Absorption; Solubility; Swine; Tamoxifen; Terpenes; Thymol | 1998 |
Treatment for hot flushes in women receiving tamoxifen.
Topics: Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride | 2002 |
In-vitro transcutaneous delivery of tamoxifen and gamma-linolenic acid from borage oil containing ethanol and 1,8-cineole.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents, Hormonal; Antirheumatic Agents; Cyclohexanols; Drug Delivery Systems; Ethanol; Eucalyptol; gamma-Linolenic Acid; In Vitro Techniques; Monoterpenes; Plant Oils; Skin; Solvents; Swine; Tamoxifen | 2004 |
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Arylsulfotransferase; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclohexanols; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Genotype; Humans; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Time Factors; Venlafaxine Hydrochloride | 2005 |
Menopausal symptoms following tamoxifen treatment for breast cancer.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride | 2008 |
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development.
Topics: Adenylyl Cyclases; Animals; Binding, Competitive; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Isomerism; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tamoxifen | 2016 |